Clinuvel Pharmaceuticals
CUV.AX
#7344
Rank
A$0.56 B
Marketcap
$11.27
Share price
-4.89%
Change (1 day)
-14.68%
Change (1 year)

Revenue for Clinuvel Pharmaceuticals (CUV.AX)

Revenue in 2024: A$88.17 Million

According to Clinuvel Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is A$93.9 Million. In 2024 the company made a revenue of A$88.17 Million an increase over the revenue in the year 2023 that were of A$78.32 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Clinuvel Pharmaceuticals from 2001 to 2024

Annual revenue

Year Revenue Change
2024A$88.17 M12.59%
2023A$78.32 M19.17%
2022A$65.72 M36.99%
2021A$47.97 M47.32%
2020A$32.56 M4.89%
2019A$31.04 M21.82%
2018A$25.48 M52.42%
2017A$16.72 M169.19%
2016A$6.21 M113.33%
2015A$2.91 M32.34%
2014A$2.2 M41.67%
2013A$1.55 M114.86%
2012A$0.72 M-30.57%
2011A$1.04 M
2010N/A
2009N/A
2008N/A-100%
2007A$0.28 M-62.47%
2006A$0.75 M505.71%
2005A$0.12 M
2004N/A
2002N/A
2001N/A